| __timestamp | Ionis Pharmaceuticals, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 241751000 | 4101058 |
| Thursday, January 1, 2015 | 322292000 | 10763215 |
| Friday, January 1, 2016 | 344320000 | 5579049 |
| Sunday, January 1, 2017 | 374644000 | 32051299 |
| Monday, January 1, 2018 | 414604000 | 24482286 |
| Tuesday, January 1, 2019 | 466000000 | 43892589 |
| Wednesday, January 1, 2020 | 535000000 | 44505000 |
| Friday, January 1, 2021 | 643000000 | 79406000 |
| Saturday, January 1, 2022 | 833000000 | 49283000 |
| Sunday, January 1, 2023 | 899625000 | 17282730 |
Data in motion
In the competitive world of biotechnology, investment in research and development (R&D) is crucial for innovation and growth. Ionis Pharmaceuticals, Inc. and Verona Pharma plc, two prominent players in the industry, have shown contrasting approaches to R&D spending over the past decade. From 2014 to 2023, Ionis Pharmaceuticals consistently outpaced Verona Pharma in R&D investment, with Ionis increasing its spending by approximately 272%, reaching nearly $900 million in 2023. In contrast, Verona Pharma's R&D expenses peaked in 2021 at around $79 million, a modest increase compared to Ionis. This disparity highlights Ionis's aggressive strategy to lead in innovation, while Verona Pharma adopts a more conservative approach. As the biotech landscape evolves, these investment strategies will play a pivotal role in shaping the future of these companies and their contributions to medical advancements.
R&D Insights: How Eli Lilly and Company and Verona Pharma plc Allocate Funds
R&D Insights: How Johnson & Johnson and Ionis Pharmaceuticals, Inc. Allocate Funds
Analyzing R&D Budgets: Merck & Co., Inc. vs Ionis Pharmaceuticals, Inc.
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Ionis Pharmaceuticals, Inc.
Research and Development Investment: Biogen Inc. vs Ionis Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Ionis Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Ionis Pharmaceuticals, Inc. vs ADMA Biologics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Analyzing R&D Budgets: Ionis Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
Research and Development: Comparing Key Metrics for Ionis Pharmaceuticals, Inc. and MannKind Corporation
Comparing Innovation Spending: Ionis Pharmaceuticals, Inc. and Dynavax Technologies Corporation
Analyzing R&D Budgets: Verona Pharma plc vs Travere Therapeutics, Inc.